MedPath

Anchen Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Established
2004-01-01
Employees
251
Market Cap
-
Website
http://anchen.com

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

1

FDA:1

Drug Approvals

Bupropion Hydrochloride

Approval Date
Jun 21, 2011
FDA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Phase 3
Completed
Conditions
Osteo Arthritis of the Knee
Interventions
Drug: Placebo
First Posted Date
2011-10-21
Last Posted Date
2012-07-12
Lead Sponsor
Anchen Pharmaceuticals, Inc
Target Recruit Count
749
Registration Number
NCT01456611
Locations
🇺🇸

Novum Investigator Site, Newport News, Virginia, United States

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

Phase 3
Completed
Conditions
Chronic Idiopathic Constipation
Interventions
Drug: Placebo
First Posted Date
2011-06-14
Last Posted Date
2012-07-12
Lead Sponsor
Anchen Pharmaceuticals, Inc
Target Recruit Count
808
Registration Number
NCT01372423
Locations
🇺🇸

Novum Investigator Site, Mountain Lake, Washington, United States

🇺🇸

Novum Invesitgator Site, Hollywood, Maryland, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.